BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Y, Zhang C, Wu T, Wang Q, Liu J, Dai P. Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells. PLoS One 2017;12:e0170609. [PMID: 28114404 DOI: 10.1371/journal.pone.0170609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang L, Lin Z, Wang Y, Gao S, Li Q, Li C, Xu W, Chen J, Liu T, Song Z, Liu G. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6. Mol Carcinog 2018;57:419-28. [DOI: 10.1002/mc.22765] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
2 Hellweg R, Mooneyham A, Bazzaro M. A Cell-Based Method for Identification of Chemotherapy Resistance Cancer Genes. Methods Mol Biol 2019;1907:83-90. [PMID: 30542992 DOI: 10.1007/978-1-4939-8967-6_6] [Reference Citation Analysis]
3 Vaughn CM, Selby CP, Yang Y, Hsu DS, Sancar A. Genome-wide single-nucleotide resolution of oxaliplatin-DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines. J Biol Chem 2020;295:7584-94. [PMID: 32299912 DOI: 10.1074/jbc.RA120.013347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Mora-Lagos B, Cartas-Espinel I, Riquelme I, Parker AC, Piccolo SR, Viscarra T, Reyes ME, Zanella L, Buchegger K, Ili C, Brebi P. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines. PLoS One 2020;15:e0228331. [PMID: 31990955 DOI: 10.1371/journal.pone.0228331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Aldossary SA. Review on Pharmacology of Cisplatin: Clinical Use, Toxicity and Mechanism of Resistance of Cisplatin. Biomed Pharmacol J 2019;12:07-15. [DOI: 10.13005/bpj/1608] [Cited by in Crossref: 43] [Cited by in F6Publishing: 10] [Article Influence: 14.3] [Reference Citation Analysis]
6 Zhuo Peng, Longfei Pan, Zequn Niu, Wei Li, Xiaoyan Dang, Lin Wan, Rui Zhang, Shuanying Yang. Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis. Oncotarget 2017;8:64143-56. [PMID: 28969058 DOI: 10.18632/oncotarget.19358] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
7 Aminuddin A, Ng PY, Leong CO, Chua EW. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. Sci Rep 2020;10:7885. [PMID: 32398775 DOI: 10.1038/s41598-020-64664-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Vennila KN, Prabha K, Sunny D, Madhuri S, Elango KP. Preparation and biological evaluation of quinoline amines as anticancer agents and its molecular docking. Med Chem Res 2019;28:1298-307. [DOI: 10.1007/s00044-019-02374-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Li H, Zhang Y, Lan X, Yu J, Yang C, Sun Z, Kang P, Han Y, Yu D. Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways. Front Cell Dev Biol 2021;9:773048. [PMID: 34901018 DOI: 10.3389/fcell.2021.773048] [Reference Citation Analysis]
10 Li S, Zhou G, Liu W, Ye J, Yuan F, Zhang Z. Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway. Oncol Res 2021;28:685-700. [PMID: 32886059 DOI: 10.3727/096504020X15917007265498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang H, Lin X, Pu X. NOD-like receptors mediate inflammatory lung injury during plateau hypoxia exposure. J Physiol Anthropol 2020;39:32. [PMID: 33028417 DOI: 10.1186/s40101-020-00242-w] [Reference Citation Analysis]
12 Sun CY, Zhang QY, Zheng GJ, Feng B. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomed Pharmacother 2019;110:518-27. [PMID: 30530287 DOI: 10.1016/j.biopha.2018.12.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
13 Sun T, Zhao Q, Zhang C, Cao L, Song M, Maimela NR, Liu S, Wang J, Gao Q, Qin G, Wang L, Zhang Y. Screening common signaling pathways associated with drug resistance in non-small cell lung cancer via gene expression profile analysis. Cancer Med 2019;8:3059-71. [PMID: 31025554 DOI: 10.1002/cam4.2190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Lang Y, Liu Z, Zheng Z. Retracted Article: Investigation of yellow horn ( Xanthoceras sorbifolia Bunge) transcriptome in response to different abiotic stresses: a comparative RNA-Seq study. RSC Adv 2020;10:6512-9. [DOI: 10.1039/c9ra09535g] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Sarin N, Engel F, Rothweiler F, Cinatl J, Michaelis M, Frötschl R, Fröhlich H, Kalayda GV. Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. Int J Mol Sci 2018;19:E767. [PMID: 29518977 DOI: 10.3390/ijms19030767] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
16 Hossian AKMN, Zahra FT, Poudel S, Abshire CF, Polk P, Garai J, Zabaleta J, Mikelis CM, Mattheolabakis G. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance. Sci Rep 2021;11:6520. [PMID: 33753779 DOI: 10.1038/s41598-021-85930-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sun CY, Zhu Y, Li XF, Wang XQ, Tang LP, Su ZQ, Li CY, Zheng GJ, Feng B. Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways. Front Pharmacol 2018;9:92. [PMID: 29487530 DOI: 10.3389/fphar.2018.00092] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
18 Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients 2018;10:E1829. [PMID: 30486290 DOI: 10.3390/nu10121829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
19 Hu T, Yu S, Li Y, Ren H, Ning Q, Wang J, Liang X, Li M. PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3. J Drug Target 2019;27:460-5. [PMID: 30457021 DOI: 10.1080/1061186X.2018.1550648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ma Q, Yang F, Mackintosh C, Jayani RS, Oh S, Jin C, Nair SJ, Merkurjev D, Ma W, Allen S, Wang D, Almenar-Queralt A, Garcia-Bassets I. Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells. Cell Rep 2020;31:107532. [PMID: 32320655 DOI: 10.1016/j.celrep.2020.107532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
21 Xu Y, Zhang C, Liang H, Hu S, Li P, Liu L, Duan X, Chen C, Zhang Y, Dai P. Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:192-200. [DOI: 10.1080/21691401.2018.1453827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]